Review Article
Korean J Hematol 2007; 42(3):
Published online September 30, 2007
https://doi.org/10.5045/kjh.2007.42.3.181
© The Korean Society of Hematology
제대혈－현황과 전망
이영호
한양대학교 의과대학 소아과학교실
Cord Blood-Current Status and Perspective
Umbilical cord blood (CB) is increasingly used as a source of stem cells to repopulate bone marrow in the treatment of life-threatening diseases in children and adults. I review the relationship between the placenta and circulating CB stem cells for hematopoiesis, the clinical results of cord blood stem cell transplantation, and I particularly emphasizethe criteria of CB donor choice. The scientific progress for the use of CB has resulted in the organization of CB banks all over the world. I also review the status of CB banks and networking systems worldwide as recipients of government-based political support.
Keywords Cord blood, Stem cell transplantation, Cord blood bank, Policy
PDF
Standard view
Export citation
Share Article
Review Article
Korean J Hematol 2007; 42(3): 181-196
Published online September 30, 2007 https://doi.org/10.5045/kjh.2007.42.3.181
Copyright © The Korean Society of Hematology.
제대혈－현황과 전망
이영호
한양대학교 의과대학 소아과학교실
Cord Blood-Current Status and Perspective
Young Ho Lee
Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea
Abstract
Umbilical cord blood (CB) is increasingly used as a source of stem cells to repopulate bone marrow in the treatment of life-threatening diseases in children and adults. I review the relationship between the placenta and circulating CB stem cells for hematopoiesis, the clinical results of cord blood stem cell transplantation, and I particularly emphasizethe criteria of CB donor choice. The scientific progress for the use of CB has resulted in the organization of CB banks all over the world. I also review the status of CB banks and networking systems worldwide as recipients of government-based political support.
Keywords: Cord blood, Stem cell transplantation, Cord blood bank, Policy
Previous Article
Article Tools
Stats or Metrics
Share this article on
Related articles in BR
-
Successful Sibling Cord Blood Stem Cell Transplantation for Relapsed Acute Mixed lineage leukemic
Young Ho Lee, Nam Cheol Cho, Ku Hwa Je, Hoon Han, Jin Yeong Han, Jae Seok Kim, Hyo Jin Kim, Bin Cho, Hack Ki Kim
Korean J Hematol 1999; 34(3): 471-476 -
Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?
Gi-June Min, Byung-Sik Cho, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Seung-Ah Yahng, Seung-Hawn Shin, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Blood Res 2022; 57(3): 197-206 -
The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
Ryul Kim, Youngil Koh, Dong-Yeop Shin, Pyoeng Gyun Choe, Nam Joong Kim, Sung-soo Yoon, Myoung-don Oh, Wan Beom Park, and Inho Kim
Blood Res 2017; 52(4): 300-306
